IP Library Granted Patent US 10,342,750
Granted Patent B2
US 10,342,750 · App. 15/106,280 · Granted Jul 9, 2019

Dentifrice compositions comprising zinc oxide and zinc citrate

Inventors: Michael Prencipe (Princeton Junction, NJ); Yun Xu (Guangzhou, CN); Xiao Yi Huang (Guangzhou, CN); Steven Fisher (Middlesex, NJ); Betty Won (New Brunswick, NJ); Lyndsay Schaeffer-Korbylo (Flemington, NJ)
Assignee: Colgate-Palmolive Company
A61K8/27A61Q11/00A61K2800/5922
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,342,750
App. No.
15/106,280
Granted
Jul 9, 2019
Kind
B2
Abstract

Described herein are oral care compositions comprising a combination of zinc oxide and zinc citrate, and methods of preparing and using the same.

Claims (9)

1. An oral care composition having synergistic zinc antibacterial effects comprising zinc oxide and zinc citrate wherein the amount of zinc citrate is about 0.5% by weight of the composition, and the amount of zinc oxide is about 1% by weight of the composition, and wherein the composition comprises a fluoride source selected from stannous fluoride, sodium fluoride, potassium fluoride, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride, titanium fluoride, and combinations thereof, and excludes any other fluoride source, wherein the antibacterial effects are measured as reduction in colony forming units after the composition is applied to incubated hydroxyapatite disks and incubated for 8 days, and wherein the antibacterial effects are measured after said hydroxyapatite disks are collected aseptically and transferred to a half-strength, pre-reduced, thioglycollate medium.

2. The composition of claim 1 , further comprising an orally acceptable carrier.

3. The composition of claim 1 , wherein the composition is in the form of a dentifrice.

4. The composition of claim 1 wherein the composition is in the form of a toothpaste or tooth gel.

5. The composition of claim 1 , wherein the composition comprises greater than 15%, by weight, free water.

6. A method of treating or preventing a disease or condition of the oral cavity comprising contacting an oral cavity surface of a patient in need thereof with the composition of claim 1 .

7. The method of claim 6 , wherein the disease or condition of the oral cavity is halitosis.

8. A method of reducing or inhibiting biofilm formation in an oral cavity comprising applying a composition of claim 1 .

9. The composition of claim 1 , wherein the fluoride source is selected from stannous fluoride, sodium fluoride, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2016
From: SCHAEFFER-KORBYLO, LYNDSAY
To: COLGATE-PALMOLIVE COMPANY
Reel/Frame 039204/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2016
From: PRENCIPE, MICHAEL; XU, YUN; HUANG, XIAO YI; FISHER, STEVEN; WON, BETTY
To: COLGATE-PALMOLIVE COMPANY
Reel/Frame 038949/0259 →
Priority Claims (1)
CN 2013 1 0701692 · Dec 19, 2013 · national
Continuity (1)
Related Publication 20160303010A1 · Oct 20, 2016
Cited By (4)
US 12,343,414 US 12,594,224 US 12,622,865 US 12,629,321